Citation: | Sun Xiaofeng, . Clinical Study of Advanced Nonsmall Cell Lung Cancer Treated with Navelbine and Clsplatin[J]. Cancer Research on Prevention and Treatment, 1997, 24(6): 385-387. |
[1] |
Miller AB. Hoogstraten B. Staquet M. et al. Report-ing Results of Cancer treatment. Cancer. 1981, 47:207.
|
[2] |
李振, 恶性肿瘤的化疗和免疫. 北京:人民卫生出版社, 1989:31.
|
[3] |
Bruner KW. et al. Die chemotherapie der nicht. Kle-inzelligen bronchus karionon. Therapie der bronchuskarziman. Deutschlaud. 1988:75.
|
[4] |
Goldber RM, et l. Bolus versus infusion regiments of Etoposide and Cisplatin in treatment of nonsmall cell lung cancer: A study of the north central carcer treat-ment group. J Natl Cancer Inst. 1990, 82(24):1889.
|
[5] |
Yamaji Y, et al. Adriamycin. Cisplatin and Etoposide combination chemotherapy in non-small cell lung can-cer. Gan to Kagaku Ryoho(Japan), 18(4):601.
|
[6] |
FV Fossella, et al. M.D. Anderson Cancer Center. Houston tex USA, 1991:77030.
|
[7] |
Elliott JA, et al. Superiority of VDS.DDP over VDs alone for Nscle. Abstract, 2nd. Amisterdam:Euro-pean. Conference on clinical Oncology and Cancer Nursing, 1983.
|
[8] |
管忠震, 等. Navelbine治疗晚期肺癌的I期临床研究报告. 癌症, 1993, 12(3):217.
|
[9] |
Drugs, 1992:44(Supplement 4)
|
[10] |
Fumoleau P, et al. Phase I studies with NVB in adv-anced breast cancer (ABC). J cancer Res Clin Oncol, 1990, 116(Wuppl Part I):1052.
|